Alltrna raises $109M for ‘transfer RNA’ drug vision

Alltrna raises $109M for ‘transfer RNA’ drug vision

Source: 
BioPharma Dive
snippet: 

Next-generation RNA drugmaker Alltrna has raised a $109 million Series B round, the Flagship Pioneering-incubated company announced Wednesday.